ATE200900T1 - Analoge nukleoside, wie antivirale einschliesslich inhibitoren der retroviralen reverstranskriptase und der dna polymerase des hepatitis b virus - Google Patents

Analoge nukleoside, wie antivirale einschliesslich inhibitoren der retroviralen reverstranskriptase und der dna polymerase des hepatitis b virus

Info

Publication number
ATE200900T1
ATE200900T1 AT98939041T AT98939041T ATE200900T1 AT E200900 T1 ATE200900 T1 AT E200900T1 AT 98939041 T AT98939041 T AT 98939041T AT 98939041 T AT98939041 T AT 98939041T AT E200900 T1 ATE200900 T1 AT E200900T1
Authority
AT
Austria
Prior art keywords
hepatitis
dna polymerase
reverse transcriptase
virus dna
including inhibitors
Prior art date
Application number
AT98939041T
Other languages
English (en)
Inventor
Xiao-Xiong Zhou
Nils-Gunnar Johansson
Horst Waehling
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9702957A external-priority patent/SE9702957D0/xx
Priority claimed from SE9704147A external-priority patent/SE9704147D0/xx
Priority claimed from SE9800452A external-priority patent/SE9800452D0/xx
Application filed by Medivir Ab filed Critical Medivir Ab
Application granted granted Critical
Publication of ATE200900T1 publication Critical patent/ATE200900T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT98939041T 1997-08-15 1998-08-14 Analoge nukleoside, wie antivirale einschliesslich inhibitoren der retroviralen reverstranskriptase und der dna polymerase des hepatitis b virus ATE200900T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9702957A SE9702957D0 (sv) 1997-08-15 1997-08-15 Antivirals
SE9704147A SE9704147D0 (sv) 1997-11-12 1997-11-12 Nucleosides
SE9800452A SE9800452D0 (sv) 1998-02-13 1998-02-13 Antivirals
PCT/SE1998/001467 WO1999009031A1 (en) 1997-08-15 1998-08-14 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv)

Publications (1)

Publication Number Publication Date
ATE200900T1 true ATE200900T1 (de) 2001-05-15

Family

ID=27355886

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01103370T ATE293112T1 (de) 1997-08-15 1998-08-14 3'-fluorierte guanosinderivate zur behandlung oder prophylaxe von hbv- oder retroviralen infektionen
AT98939041T ATE200900T1 (de) 1997-08-15 1998-08-14 Analoge nukleoside, wie antivirale einschliesslich inhibitoren der retroviralen reverstranskriptase und der dna polymerase des hepatitis b virus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01103370T ATE293112T1 (de) 1997-08-15 1998-08-14 3'-fluorierte guanosinderivate zur behandlung oder prophylaxe von hbv- oder retroviralen infektionen

Country Status (24)

Country Link
EP (2) EP0988304B1 (de)
JP (1) JP3844654B2 (de)
KR (1) KR100529272B1 (de)
CN (2) CN1286845C (de)
AT (2) ATE293112T1 (de)
AU (1) AU728892B2 (de)
CA (1) CA2298704C (de)
CZ (1) CZ300757B6 (de)
DE (3) DE69800753D1 (de)
DK (1) DK0988304T3 (de)
ES (2) ES2239637T3 (de)
GR (1) GR3036004T3 (de)
HK (2) HK1032968A1 (de)
HU (1) HU228060B1 (de)
IL (2) IL134503A0 (de)
MY (1) MY116269A (de)
NZ (1) NZ502837A (de)
PL (1) PL338643A1 (de)
PT (1) PT988304E (de)
SG (1) SG96604A1 (de)
SI (1) SI0988304T1 (de)
TR (2) TR200000398T2 (de)
TW (1) TW580500B (de)
WO (1) WO1999009031A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) * 1909-10-07 2002-10-01 Medivir Ab Prodrugs
FR2794752A1 (fr) * 1999-06-11 2000-12-15 Laphal Sa Lab Nouveaux composes derives de nucleosides, leurs procedes de preparation, et les compositions pharmaceutiques en renfermant
FR2796384A1 (fr) * 1999-07-12 2001-01-19 Laphal Sa Lab Nouveaux esters derives de nucleosides, leurs procedes de preparation et les compositions pharmaceutiques en renfermant
MY141789A (en) 2001-01-19 2010-06-30 Lg Chem Investment Ltd Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
AUPS037002A0 (en) * 2002-02-07 2002-02-28 Melbourne Health Viral variants and uses therefor
WO2004087139A1 (en) * 2003-03-27 2004-10-14 Boehringer Ingelheim International Gmbh Antiviral combination of tipranavir and a further antiretroviral compound
WO2004087169A1 (en) * 2003-03-27 2004-10-14 Boehringer Ingelheim International Gmbh Antiviral combination of nevirapine and a further antiretroviral compound
EP1610782A1 (de) * 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antivirale kombination eines dipyridodiazepinons und einer weiteren antiretroviralen verbindung
GB0400290D0 (en) 2004-01-08 2004-02-11 Medivir Ab dUTPase inhibitors
GB0513835D0 (en) 2005-07-07 2005-08-10 Medivir Ab HIV inhibitors
CN103347871A (zh) * 2011-02-21 2013-10-09 美迪维尔公司 Flg的合成
AU2016328150B2 (en) * 2015-09-23 2020-10-01 Xw Laboratories Inc. Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
WO2021074443A1 (en) * 2019-10-17 2021-04-22 Ai-Biopharma Anti-viral and hepatic-targeted drugs
CN114686188B (zh) * 2020-12-31 2023-05-02 中石化石油工程技术服务有限公司 一种核苷磷脂钻井液润滑剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8602981D0 (sv) * 1986-07-04 1986-07-04 Astra Laekemedel Ab Novel medicinal use
GB8719367D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Therapeutic compounds
WO1989003837A1 (en) * 1987-10-28 1989-05-05 Pro-Neuron, Inc. Acylated uridine and cytidine and uses thereof
EP0375329B1 (de) * 1988-12-19 1995-05-31 The Wellcome Foundation Limited Antivirale Pyrimidin- und Purinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
ATE179615T1 (de) * 1991-02-08 1999-05-15 Pro Neuron Inc Oxypurin-nukleoside und seine artverwandten, und acylderivate davon, zur verbesserung der hämatopoese
DE4311801A1 (de) * 1993-04-09 1994-10-13 Hoechst Ag Neue Carbonsäureester von 2-Amino-7-(1,3-dihydroxy-2-propoxymethyl)purin, deren Herstellung sowie deren Verwendung
PE32296A1 (es) * 1994-07-28 1996-08-07 Hoffmann La Roche Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables
AU1592897A (en) * 1996-01-26 1997-08-20 F. Hoffmann-La Roche Ag Process for preparing purine derivatives
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
JP2001503767A (ja) * 1996-11-12 2001-03-21 メディヴィル・アクチボラグ ヌクレオシド

Also Published As

Publication number Publication date
MY116269A (en) 2003-12-31
JP2001515079A (ja) 2001-09-18
AU728892B2 (en) 2001-01-18
CA2298704A1 (en) 1999-02-25
TR200000398T2 (tr) 2000-07-21
DE69800753T2 (de) 2001-10-25
DE69800753D1 (de) 2001-06-07
TW580500B (en) 2004-03-21
EP1123935B1 (de) 2005-04-13
IL134503A0 (en) 2001-04-30
ES2239637T3 (es) 2005-10-01
CA2298704C (en) 2006-07-11
NZ502837A (en) 2001-01-26
CZ2000449A3 (cs) 2000-08-16
DE69829784D1 (de) 2005-05-19
CN1130362C (zh) 2003-12-10
HUP0100087A3 (en) 2003-01-28
CN1286845C (zh) 2006-11-29
PT988304E (pt) 2001-10-31
HK1097550A1 (en) 2007-06-29
IL134503A (en) 2010-06-30
EP1123935A3 (de) 2001-09-05
ATE293112T1 (de) 2005-04-15
WO1999009031A1 (en) 1999-02-25
GR3036004T3 (en) 2001-09-28
DK0988304T3 (da) 2001-08-20
HUP0100087A1 (hu) 2002-01-28
EP0988304B1 (de) 2001-05-02
DE69800753T4 (de) 2002-02-21
KR20010022873A (ko) 2001-03-26
AU8754898A (en) 1999-03-08
TR200002273T2 (tr) 2002-06-21
PL338643A1 (en) 2000-11-06
ES2158689T3 (es) 2001-09-01
DE69829784T2 (de) 2006-02-16
JP3844654B2 (ja) 2006-11-15
EP1123935A2 (de) 2001-08-16
SI0988304T1 (en) 2001-08-31
EP0988304A1 (de) 2000-03-29
CN1500800A (zh) 2004-06-02
KR100529272B1 (ko) 2005-11-17
CZ300757B6 (cs) 2009-08-05
CN1275983A (zh) 2000-12-06
HK1032968A1 (en) 2001-08-10
SG96604A1 (en) 2003-06-16
HU228060B1 (en) 2012-09-28

Similar Documents

Publication Publication Date Title
HK1097550A1 (en) Antiviral nucleoside analogues as inhibitors of retroviral reverse transcriptase and dna polymerase
DE69801802T2 (de) Substituierte propargylethoxyamido-nukleoside
DK0663922T3 (da) Nukleotider mærket med infrarødt farvestof og deres anvendelse til nukleinsyredetektion
DE60325692D1 (de) Pyrimidinonen als virale polymerase inhibitoren
PA8483101A1 (es) Compuestos quimicos
TR200100438T2 (tr) Hepatit C inhibitörü peptitler
DK0777679T3 (da) Indføring af nukleinsyrer
JP2002503673A5 (de)
KR920700202A (ko) 아크릴로일 치환된 피롤 유도체
NO20084343L (no) Fremgangsmate for fremstilling av 6-(4-fenylbutoksy)heksylaminderivater
DK0489836T3 (da) Lysaktiverede acyl-enzymer
ES2164869T3 (es) Conjugados lipidos especificos de nucleosidos-difosfato y su uso como medicamentos.
EA200100711A1 (ru) Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
ES2186127T3 (es) Sintesis de derivados de nucleosidos aciclicos.
RS50072B (sr) S-nitrozotioli kao agensi za tretman cirkulatornih poremećaja
ATE230400T1 (de) Melamin-azomethin-derivate und ein diese enthaltendes korrosionsschutzmittel
ES2098084T3 (es) Procedimiento para la acilacion de derivados de treonina y su uso para la preparacion de 1,4-dihidropiridinas.
RU2002102009A (ru) Оптически активные амиды 1-(4-хлорбензоил)-5-метокси-2-метилиндол-3-уксусной кислоты с производными (S)-аминокислот
AR029153A1 (es) Analogos de nucleosido antivirales

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification